Dr. Ramesh Hariharan Honoured At International Symposium

Dr. Ramesh Hariharan is the co-founder and CEO at Strand, and adjunct professor at the Computer Science department of the Indian Institute of Science (IISc), Bangalore

Strand Life Sciences, a genomics-based research and diagnostics company, is proud to announce that its CEO, Dr. Ramesh Hariharan, has been honoured at the International Symposium on Precision Oncology & Personalized Medicine held by the Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute in Mumbai. Ms. Tina Ambani, Chairperson of the hospital, presented the award to Dr. Hariharan, recognizing his exceptional work and innovative contributions to the genomic industry in India.

At Strand, over the last 15 years, Dr. Ramesh has led teams building analytical tools for high-throughput molecular profiling; these tools are widely used and have been cited in several thousand publications. More recently, Dr. Ramesh and the team at Strand have been working on technology to make DNA sequencing for genetic disease diagnosis affordable in India. Dr. Ramesh is a recipient of the TR100 Award of Young Innovators by MIT’s Technology Review Magazine and in 2003 received the Global Indus Technovator Award from MIT, instituted to recognize the Top 20 Indian Technology Innovators worldwide.

Dr. Ramesh received his B. Tech from the IIT, Delhi, his Ph. D from the Courant Institute of Mathematical Sciences, New York University, and subsequently did a postdoc at the Max-Planck Institut fur Informatik in Saarbrucken, Germany.Dr. Ramesh was recently inducted as a Fellow of the Indian Academy of Sciences. IIT, Delhi recognized him as the Distinguished Alumnus for the year 2015.

Commenting on the recognition, Dr. Ramesh Hariharan, CEO and Co-Founder, Strand Life Sciences, said, "I am deeply honoured to receive this recognition from such a distinguished group of leaders in the oncology field. This recognition further strengthens our commitment to enabling precision medicine for all and motivates us to continue our efforts in revolutionizing the genomic industry in India.”

The symposium provided an opportunity for top oncologists from India, the USA, and other countries to come together and discuss the latest advances in precision oncology and personalized medicine.